Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.65% |
| 3 | Consumer Staples | 12.19% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Meritage Homes
MTH
$4.72B
| $2.09M | ﹤0.01% |
37,800
-116,600
| -76% | -$5.58M |
|
|
EXPR
2102
DELISTED
Express, Inc.
EXPR
| $2.08M | ﹤0.01% |
170,895
-33,010
| -16% | -$731K |
|
|
ACB
2103
Aurora Cannabis
ACB
$175M
| $2.08M | ﹤0.01% |
+44,738
| New | +$4.25M |
|
|
GEN
2104
DELISTED
Genesis Healthcare, Inc.
GEN
| $2.08M | ﹤0.01% |
3,824,346
-487,717
| -11% | -$351K |
|
2105
Core Laboratories
CLB
$484M
| $2.08M | ﹤0.01% |
136,093
-198,355
| -59% | -$4.16M |
|
2106
Global Indemnity Group
GBLI
$399M
| $2.08M | ﹤0.01% |
99,834
-17,216
| -15% | -$406K |
|
2107
Neuronetics
STIM
$146M
| $2.07M | ﹤0.01% |
426,561
-215,757
| -34% | -$819K |
|
|
FRG
2108
DELISTED
Franchise Group, Inc.
FRG
| $2.07M | ﹤0.01% |
81,500
+49,900
| +158% | +$1.19M |
|
2109
Fate Therapeutics
FATE
$284M
| $2.06M | ﹤0.01% |
+51,619
| New | +$1.8M |
|
2110
Philips
PHG
$26B
| $2.06M | ﹤0.01% |
53,915
-72,665
| -57% | -$2.92M |
|
2111
Minerva Neurosciences
NERV
$185M
| $2.06M | ﹤0.01% |
80,963
-8,725
| -10% | -$236K |
|
2112
Orion Group Holdings
ORN
$403M
| $2.06M | ﹤0.01% |
749,197
-140,000
| -16% | -$400K |
|
2113
iShares MSCI Australia ETF
EWA
$1.4B
| $2.06M | ﹤0.01% |
+104,400
| New | +$2.11M |
|
2114
Pitney Bowes
PBI
$2.43B
| $2.06M | ﹤0.01% |
387,700
-417,800
| -52% | -$1.93M |
|
2115
Walker & Dunlop
WD
$1.73B
| $2.06M | ﹤0.01% |
38,800
+25,100
| +183% | +$1.32M |
|
|
ACGN
2116
DELISTED
Aceragen Inc
ACGN
| $2.05M | ﹤0.01% |
56,505
-4,258
| -7% | -$151K |
|
|
COWN
2117
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.05M | ﹤0.01% |
+126,228
| New | +$2.15M |
|
2118
Ichor Holdings
ICHR
$2.62B
| $2.05M | ﹤0.01% |
95,190
-70,810
| -43% | -$1.88M |
|
|
CWBC
2119
Community West Bancshares
CWBC
$688M
| $2.05M | ﹤0.01% |
165,956
-1,925
| -1% | -$25K |
|
|
LBC
2120
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.04M | ﹤0.01% |
244,068
-6,300
| -3% | -$58.8K |
|
|
SIOX
2121
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.04M | ﹤0.01% |
440,923
-245,000
| -36% | -$809K |
|
|
HNP
2122
DELISTED
Huaneng Power Intl, Inc.
HNP
| $2.03M | ﹤0.01% |
131,700
-9,000
| -6% | -$149K |
|
2123
Valhi
VHI
$391M
| $2.03M | ﹤0.01% |
154,251
+10,300
| +7% | +$124K |
|
2124
Invesco Financial Preferred ETF
PGF
$675M
| $2.03M | ﹤0.01% |
108,100
+53,600
| +98% | +$995K |
|
2125
Transact Technologies
TACT
$53.6M
| $2.02M | ﹤0.01% |
404,589
-12,308
| -3% | -$58.2K |
|
Similar funds
Renaissance Technologies's Q3 2020 Portfolio in Review
As of Q3 2020, Renaissance Technologies held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Microsoft worth $277M.
- Renaissance Technologies's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Renaissance Technologies added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Renaissance Technologies's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Renaissance Technologies fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Renaissance Technologies's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Renaissance Technologies opened 490 new positions and closed 544 in Q3 2020.
- Renaissance Technologies's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.